Chapelier A R, Bacha E A, de Montpreville V T, Dulmet E M, Rietjens M, Margulis A, Macchiarini P, Dartevelle P G
Department of Thoracic and Vascular Surgery, Hôpital Marie-Lannelongue, Paris-Sud University, Le Plessis-Robinson, France.
Ann Thorac Surg. 1997 Jan;63(1):214-9. doi: 10.1016/s0003-4975(96)00927-7.
Surgical management of radiation-induced sarcoma of the chest wall remains difficult because of its impressive local aggressiveness.
Between 1987 and 1995, 15 patients (median age, 58 years) underwent radical resection of radiation-induced sarcoma of the chest wall. This type of tumor was defined as a metachronous, histologically different neoplasm in the irradiated field of the original tumor. Ten patients had a history of primary breast cancer and 5 patients, Hodgkin's disease. The median delivered radiation dose to the primary tumor area was 45 Gy, and the median interval between radiotherapy and diagnosis of sarcoma was 14 years. Seven tumors were located on the sternum, three on the lateral chest wall, and five in the thoracic outlet. Four total and three partial sternectomies, three lateral chest wall resections and five resections of tumors in the thoracic outlet (three first-rib resections) were performed. Seven patients required stabilization of the chest wall with prosthetic material. Soft tissue reconstruction was carried out with either muscle flaps and skin advancement in 9, musculocutaneous flaps in 4, or skin flaps alone in 2 patients.
One patient died 3 months after total sternectomy of respiratory failure. Two patients (13.3%) had a local complication: sepsis after sternectomy in 1 and cutaneous necrosis in 1. Local recurrence occurred in 7 patients after a median interval of 10 months. Two of them died, and 4 underwent a repeat resection, 3 of whom are still alive. Four patients died of systemic recurrence. With a median follow-up of 30 months, overall 5-year survival and 5-year disease-free survival rates were 48% and 27%, respectively.
Despite poor long-term disease-free survival, radical resection of radiation-induced sarcoma of the chest wall is justified on the basis of low postoperative morbidity and the lack of other available therapies.
由于胸壁放射性肉瘤具有显著的局部侵袭性,其外科治疗仍然困难。
1987年至1995年间,15例患者(中位年龄58岁)接受了胸壁放射性肉瘤根治性切除术。这类肿瘤被定义为在原肿瘤放疗区域内发生的异时性、组织学不同的肿瘤。10例患者有原发性乳腺癌病史,5例患者有霍奇金病病史。原发肿瘤区域接受的中位放疗剂量为45 Gy,放疗与肉瘤诊断之间的中位间隔时间为14年。七个肿瘤位于胸骨,三个位于胸壁外侧,五个位于胸廓出口。实施了四例全胸骨切除术和三例部分胸骨切除术、三例胸壁外侧切除术以及五例胸廓出口肿瘤切除术(三例第一肋切除术)。七例患者需要使用假体材料稳定胸壁。9例患者采用肌瓣和皮瓣推进进行软组织重建,4例采用肌皮瓣,2例仅采用皮瓣。
1例患者在全胸骨切除术后3个月死于呼吸衰竭。2例患者(13.3%)出现局部并发症:1例胸骨切除术后发生败血症,1例出现皮肤坏死。7例患者出现局部复发,中位间隔时间为10个月。其中2例死亡,4例接受了再次切除,3例仍然存活。4例患者死于全身复发。中位随访30个月,5年总生存率和5年无病生存率分别为48%和27%。
尽管长期无病生存率较低,但基于术后发病率低以及缺乏其他可用治疗方法,胸壁放射性肉瘤根治性切除术是合理的。